Tyers Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Tyers Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,402	Closed	-$80K	–	1001
2018 Q1	$80K	Sell	6,402 -19,250	-75%	-$234K	﹤0.01%	883
2017 Q4	$358K	Sell	25,652 -12,848	-33%	-$188K	0.01%	526
2017 Q3	$647K	Sell	38,500 -4,796	-11%	-$78.1K	0.02%	341
2017 Q2	$728K	Sell	43,296 -14,454	-25%	-$216K	0.03%	330
2017 Q1	$895K	Hold	57,750	–	–	0.03%	297
2016 Q4	$863K	Buy	+57,750	New	+$811K	0.04%	276

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Tyers Asset Management's OXFD Position: Q2 2018 in Review

Tyers Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 6,402 shares — an estimated $80K sold.

Tyers Asset Management first reported a position in OXFD in Q4 2016 and held it in 6 quarters. The position peaked at $895K in Q1 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

Tyers Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
Tyers Asset Management sold 6,402 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $80K.
Tyers Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 6 quarters.
Tyers Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $895K in Q1 2017.
77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Tyers Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.